SCHEMBL24718729

SCHEMBL24718729

CO[C@H]1C[C@H](N2CCN(C3CNC3)CC2)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.32
HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24717700 0.81 HTR6 (0.36) HTR6
SCHEMBL24717621 0.81 HTR6 (0.36) HTR6
SCHEMBL21570134 0.81 HTR6 (0.36) KHKHTR6
Hydrochloric Acid SCHEMBL2476511 0.79 HTR6 (0.35) HTR6
SCHEMBL24185173 0.78 KDM4E (0.34)
SCHEMBL24717881 0.78 KDM4E (0.34)
SCHEMBL24718323 0.78 HRH3 (0.37) HTR6
SCHEMBL24996299 0.78 HRH3 (0.34)
SCHEMBL24995530 0.78 HRH3 (0.37) HTR6
SCHEMBL26510202 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220395576-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2022-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395576-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE BCL6, BCL6B, BCL3 KHK 3887/4885HTR6 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.